Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2022

Nov 25, 2022

60507_rns_2022-11-25_aa43b322-8092-4a17-8774-d7062ff55a4a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

November 25, 2022

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1st Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2022.

The said disclosure is also available on the website of the Company i.e., www.pfizerltd.co.in

Please take the above on record

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [98 x 19] intentionally omitted <==

----- Start of picture text ----- PRAJEET----- End of picture text -----

NAIR

Digitally signed by PRAJEET NAIR DN: c=IN, o=Personal, 2.5.4.20=9933a48702916ad69ca05ea07b057e4a4737e501e6 5094b9d54663b70517bbe5, postalCode=400054, st=MAHARASHTRA, serialNumber=c24aea3eb0ba76c8cf19782a6242b9b35252d6 b9461f59c3998022881b762db1, cn=PRAJEET NAIR, l=MUMBAI, title=7345, pseudonym=734520210415120738822, email=[email protected] Date: 2022.11.25 16:19:07 +05'30'

Prajeet Nair Director – Corporate Services & Company Secretary

Encl.: A/a

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015 for the half year ended September 30, 2022.

Sr.no Details oflisted entittransactio the partyy entering into then Details of the c ounter party Type of related party trans action Value of the related partytransaction as approvedby the audit committee Remarks on approval by AuditCommittee Value of transactionduring the reportingperiod In case monies are due to either partyas a result of the transaction
Name PAN Name Relationship of the counterparty with Opening balance Closing balance
the listed entity or its subsidiary
1 Pfizer Limi ted AAACP3334M Pfizer Service C ompany BVBA, Belgium Fellow subsidiary Purchase of goods or servic es 238.28 On arm's length basis and inOrdinary course of business 238.28 81.60 33.53
2 Pfizer Limi ted AAACP3334M Pfizer Healthca re India Private Limited Fellow subsidiary Service Income 1.97 On arm's length basis and inOrdinary course of business 1.97 5.74 -1.97
3 Pfizer Limi ted AAACP3334M Pfizer Products India Private Limited Fellow subsidiary Service Income 9.14 On arm's length basis and inOrdinary course of business 9.14 -3.90 -10.02
4 Pfizer Limi ted AAACP3334M Pfizer Export B. V. Fellow subsidiary Service Income 0.32 On arm's length basis and inOrdinary course of business 0.32 -2.05 -0.32
5 Pfizer Limi ted AAACP3334M Pfizer Worldwi de Services Company Fellow subsidiary Service Income 28.74 On arm's length basis and inOrdinary course of business 28.74 -13.03 -33.27
6 Pfizer Limi ted AAACP3334M Pfizer Corporat ion Hong Kong Limited Fellow subsidiary Re-imbursement of Expens e 0.01 On arm's length basis and inOrdinary course of business 0.01 0.00 0.01
7 Pfizer Limi ted AAACP3334M Pfizer Overseas LLC Fellow subsidiary Inter Company Write Back 0.25 On arm's length basis and inOrdinary course of business 0.25 0.35 -
8 Pfizer Limi ted AAACP3334M Pfizer Products India Private Limited Fellow subsidiary Recovery of Expenses 0.17 On arm's length basis and inOrdinary course of business 0.17 - -
9 Pfizer Limi ted AAACP3334M John Wyeth & Brother Ltd Company collectively exercisingsignificant influence Dividend paid 5.73 On arm's length basis and inOrdinary course of business 5.73 2.44 2.50
10 Pfizer Limi ted AAACP3334M Parke, Davis & Company LLC Fellow subsidiary Dividend paid 6.21 On arm's length basis and inOrdinary course of business 6.21 - -
11 Pfizer Limi ted AAACP3334M Pfizer East India BV Fellow subsidiary Dividend paid 118.21 On arm's length basis and inOrdinary course of business 118.21 - -
12 Pfizer Limi ted AAACP3334M Pharmacia LLC Fellow subsidiary Dividend paid 5.10 On arm's length basis and inOrdinary course of business 5.10 - -
13 Pfizer Limi ted AAACP3334M Warner-Lambe rt Company LLC Fellow subsidiary Dividend paid 7.72 On arm's length basis and inOrdinary course of business 7.72 - -
14 Pfizer Limi ted AAACP3334M Wyeth Holding s LLC Fellow subsidiary Dividend paid 10.60 On arm's length basis and inOrdinary course of business 10.60 - -
15 Pfizer Limi ted AAACP3334M Wyeth LLC Fellow subsidiary Dividend paid 36.52 On arm's length basis and inOrdinary course of business 36.52 - -
20 Pfizer Limi ted AAACP3334M Mr. Pradip Sha h Independent Director Sitting Fees 0.04 On arm's length basis and inOrdinary course of business 0.04 - -
21 Pfizer Limited AAACP3334M Mr. Uday Khanna Independent Director Sitting Fees 0.03 On arm's length basis and inOrdinary course of business 0.03 - -
22 Pfizer Limited AAACP3334M Mr. Sunil Lalbhai Independent Director Sitting Fees 0.03 On arm's length basis and inOrdinary course of business 0.03 - -
23 Pfizer Limited AAACP3334M Ms. Meena Ganesh Independent Director Sitting Fees 0.02 On arm's length basis and inOrdinary course of business 0.02 - -
16 Pfizer Limited AAACP3334M Mr. S. Sridhar Key Managerial Personnel Remuneration 4.13 On arm's length basis and inOrdinary course of business 4.13 - -
17 Pfizer Limited AAACP3334M Mr. Milind Patil Key Managerial Personnel Remuneration 2.15 On arm's length basis and inOrdinary course of business 2.15 - -
18 Pfizer Limited AAACP3334M Mr. Samir Kazi Key Managerial Personnel Remuneration 1.42 On arm's length basis and inOrdinary course of business 1.42 - -
19 Pfizer Limited AAACP3334M Mr. Prajeet Nair Key Managerial Personnel Remuneration 0.40 On arm's length basis and inOrdinary course of business 0.40 - -